Capillary Technologies India Ltd.

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) and the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (‘SEBI (SBEBSE) Regulations’), as amended from time to time, and in supersession of our earlier intimation dated July 1, 2026, Capillary Technologies India has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company, by way of a revised resolution by circulation approved on July 3, 2026, has granted 7,92,636 stock options of face value ?2/- each to eligible employees of the Company under the ESOP Plan 2021. The details pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January, 2026, as amended from time to time (‘SEBI Circulars’), with respect to the aforesaid grant of ESOPs is enclosed as an Annexure-I. The above information is also available on the Company’s website at https://www.capillarytech.com/investors/shareholder-information/corporateannouncements/.

The above information is a part of company’s filings submitted to BSE.